Cargando…

Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy

Glutathione (GSH) is the predominant low-molecular-weight antioxidant with a ubiquitous distribution inside the cell. The steady-state level of cellular GSH is dependent on the balance between synthesis, hydrolysis, recycling of glutathione disulphide (GSSG) as well as cellular extrusion of reduced,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desideri, Enrico, Ciccarone, Fabio, Ciriolo, Maria Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724225/ https://www.ncbi.nlm.nih.gov/pubmed/31426306 http://dx.doi.org/10.3390/nu11081926

Ejemplares similares

Lipid Catabolism and ROS in Cancer: A Bidirectional Liaison
por: Castelli, Serena, et al.
Publicado: (2021)

Glutathione and Nitric Oxide: Key Team Players in Use and Disuse of Skeletal Muscle
por: Baldelli, Sara, et al.
Publicado: (2019)

Endothelial Ca(2+) Signaling and the Resistance to Anticancer Treatments: Partners in Crime
por: Moccia, Francesco
Publicado: (2018)

Epigenetic Insights on PARP-1 Activity in Cancer Therapy
por: Pinton, Giulia, et al.
Publicado: (2022)

Partners in Crime: Towards New Ways of Targeting Calcium Channels
por: Noyer, Lucile, et al.
Publicado: (2019)

Mutant p53 partners in crime
por: Kim, Michael P, et al.
Publicado: (2018)

Adipose Tissue and FoxO1: Bridging Physiology and Mechanisms
por: Ioannilli, Laura, et al.
Publicado: (2020)

Hindering NAT8L expression in hepatocellular carcinoma increases cytosolic aspartate delivery that fosters pentose phosphate pathway and purine biosynthesis promoting cell proliferation
por: De Falco, Pamela, et al.
Publicado: (2022)

Oxidative Stress-Driven Autophagy acROSs Onset and Therapeutic Outcome in Hepatocellular Carcinoma
por: Ciccarone, Fabio, et al.
Publicado: (2019)

LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
por: Russo, Isabella, et al.
Publicado: (2014)

Partners in crime: neutrophils and monocytes/macrophages in inflammation and disease
por: Prame Kumar, Kathryn, et al.
Publicado: (2018)

Partners in Crime: The Interplay of Proteins and Membranes in Regulated Necrosis
por: Ros, Uris, et al.
Publicado: (2020)

Netrin-1 in Glioblastoma Neovascularization: The New Partner in Crime?
por: Vásquez, Ximena, et al.
Publicado: (2021)

α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
por: Bigi, Alessandra, et al.
Publicado: (2023)

Sympathetic activity in breast cancer and metastasis: partners in crime
por: Conceição, Francisco, et al.
Publicado: (2021)

Hints on ATGL implications in cancer: beyond bioenergetic clues
por: Vegliante, Rolando, et al.
Publicado: (2018)

Partners in crime: the TGFβ and MAPK pathways in cancer progression
por: Chapnick, Douglas A, et al.
Publicado: (2011)

iPSCs and Exosomes: Partners in Crime Fighting Cardiovascular Diseases
por: Germena, Giulia, et al.
Publicado: (2021)

The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies
por: Jaganjac, Morana, et al.
Publicado: (2020)

Inhibition of JNK increases the sensitivity of hepatocellular carcinoma cells to lysosomotropic drugs via LAMP2A destabilization
por: Desideri, Enrico, et al.
Publicado: (2021)

Genetic engineering of mesenchymal stromal cells for cancer therapy: turning partners in crime into Trojan horses
por: Niess, Hanno, et al.
Publicado: (2016)

New approaches regarding the in vitro maturation of oocytes: manipulating cyclic nucleotides and their partners in crime
por: Botigelli, Ramon Cesar, et al.
Publicado: (2017)

HIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic Targets
por: Vyboh, Kishanda, et al.
Publicado: (2015)

MYC and the unfolded protein response in cancer: synthetic lethal partners in crime?
por: Zhang, Tingting, et al.
Publicado: (2020)

Brain-derived neurotrophic factor and inflammation in depression: Pathogenic partners in crime?
por: Porter, Grace A, et al.
Publicado: (2022)

Partners in Crime: NGF and BDNF in Visceral Dysfunction
por: Coelho, Ana, et al.
Publicado: (2019)

Partners in Crime in the Setting of Recurring Cardiac Arrest
por: Papavasileiou, Lida P., et al.
Publicado: (2011)

Brucella and Osteoarticular Cell Activation: Partners in Crime
por: Giambartolomei, Guillermo H., et al.
Publicado: (2017)

The Engagement Between MDSCs and Metastases: Partners in Crime
por: Trovato, Rosalinda, et al.
Publicado: (2020)

Right or Left Heart Failure: Partners in Crime
por: Wu, Cho-Kai, et al.
Publicado: (2022)

Partners in crime: POPX2 phosphatase and its interacting proteins in cancer
por: Kim, Pu Rum, et al.
Publicado: (2020)

ROS-dependent HIF1α activation under forced lipid catabolism entails glycolysis and mitophagy as mediators of higher proliferation rate in cervical cancer cells
por: Castelli, Serena, et al.
Publicado: (2021)

SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime
por: Domingues, Renato, et al.
Publicado: (2020)

Unraveling the Role of Epicardial Adipose Tissue in Coronary Artery Disease: Partners in Crime?
por: Conceição, Glória, et al.
Publicado: (2020)

Partners in crime: The feedback loop between metabolic reprogramming and immune checkpoints in the tumor microenvironment
por: Benito-Lopez, Jesus J., et al.
Publicado: (2023)

COX-2 and EGFR: Partners in Crime Split by Aspirin
por: Patrignani, Paola, et al.
Publicado: (2015)

P376: Dirty bedpans and MDRO: partners in crime?
por: Van Knippenberg-Gordebeke, GG
Publicado: (2013)

Partners in crime: two prisoners with foreign body insertion
por: Kozana, Androniki, et al.
Publicado: (2020)

Hypertension and Dyslipidemia: the Two Partners in Endothelium-Related Crime
por: Dąbrowska, Edyta, et al.
Publicado: (2023)

Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime
por: Pradip, De, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cov4g2uoqrc6ak2oc15l7d52o5